Lack of benefit from low dose computed tomography in screening for lung cancer - comment on paper by Huang K-L et al
- PMID: 32847558
- PMCID: PMC7450544
- DOI: 10.1186/s12890-020-01252-1
Lack of benefit from low dose computed tomography in screening for lung cancer - comment on paper by Huang K-L et al
Abstract
The article by Huang K-L et al. Effects of low-dose computed tomography (LDCT) screening on lung cancer contains a conclusion that is not consistent with the data presented. With reference to the National Lung Screening Trial (NLST) there are several flaws in the methodology overlooked. Also there is no significant reduction in deaths from all causes following the screening. Therefore any claim that the LDCT screening is superior to usual care is invalid.
Keywords: Low dose computed tomography; Lung cancer screening; Methodology.
Conflict of interest statement
The author declares that he has no competing interests.
Comment in
-
Author response to "lack of benefit from low dose computed tomography in screening for lung cancer".BMC Pulm Med. 2020 Aug 26;20(1):226. doi: 10.1186/s12890-020-01247-y. BMC Pulm Med. 2020. PMID: 32847562 Free PMC article.
Comment on
-
Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis.BMC Pulm Med. 2019 Jul 11;19(1):126. doi: 10.1186/s12890-019-0883-x. BMC Pulm Med. 2019. PMID: 31296196 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
